203 related articles for article (PubMed ID: 31835137)
1. HPV33+ HNSCC is associated with poor prognosis and has unique genomic and immunologic landscapes.
Chatfield-Reed K; Gui S; O'Neill WQ; Teknos TN; Pan Q
Oral Oncol; 2020 Jan; 100():104488. PubMed ID: 31835137
[TBL] [Abstract][Full Text] [Related]
2. Identifying predictors of HPV-related head and neck squamous cell carcinoma progression and survival through patient-derived models.
Facompre ND; Rajagopalan P; Sahu V; Pearson AT; Montone KT; James CD; Gleber-Netto FO; Weinstein GS; Jalaly J; Lin A; Rustgi AK; Nakagawa H; Califano JA; Pickering CR; White EA; Windle BE; Morgan IM; Cohen RB; Gimotty PA; Basu D
Int J Cancer; 2020 Dec; 147(11):3236-3249. PubMed ID: 32478869
[TBL] [Abstract][Full Text] [Related]
3. Distinct immune evasion in APOBEC-enriched, HPV-negative HNSCC.
Messerschmidt C; Obermayer B; Klinghammer K; Ochsenreither S; Treue D; Stenzinger A; Glimm H; Fröhling S; Kindler T; Brandts CH; Schulze-Osthoff K; Weichert W; Tinhofer I; Klauschen F; Keilholz U; Beule D; Rieke DT
Int J Cancer; 2020 Oct; 147(8):2293-2302. PubMed ID: 32468570
[TBL] [Abstract][Full Text] [Related]
4. Identification of Immune-Related Prognostic Biomarkers Associated with HPV-Positive Head and Neck Squamous Cell Carcinoma.
Chen Y; Nie J; Li X; Fan T; Deng X; Liang D; Song G
J Immunol Res; 2021; 2021():6661625. PubMed ID: 33506058
[TBL] [Abstract][Full Text] [Related]
5. HPV Meets APOBEC: New Players in Head and Neck Cancer.
Riva G; Albano C; Gugliesi F; Pasquero S; Pacheco SFC; Pecorari G; Landolfo S; Biolatti M; Dell'Oste V
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573337
[TBL] [Abstract][Full Text] [Related]
6. Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
Li J; Tang LL; Ma J
BMC Cancer; 2022 Jun; 22(1):714. PubMed ID: 35768785
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of the tumor microbiome, molecular profiles, and immune cell abundances by HPV status in mucosal head and neck cancers and their impact on survival.
Upadhyay R; Dhakal A; Wheeler C; Hoyd R; Jagjit Singh M; Karivedu V; Bhateja P; Bonomi M; Valentin S; Gamez ME; Konieczkowski DJ; Baliga S; Grecula JC; Blakaj DM; Gogineni E; Mitchell DL; Denko NC; Spakowicz D; Jhawar SR
Cancer Biol Ther; 2024 Dec; 25(1):2350249. PubMed ID: 38722731
[TBL] [Abstract][Full Text] [Related]
8. Plasma cell marker, immunoglobulin J polypeptide, predicts early disease-specific mortality in HPV+ HNSCC.
Gui S; O'Neill WQ; Teknos TN; Pan Q
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737336
[TBL] [Abstract][Full Text] [Related]
9. Association of Tumor Site With the Prognosis and Immunogenomic Landscape of Human Papillomavirus-Related Head and Neck and Cervical Cancers.
Zhu G; Amin N; Herberg ME; Maroun CA; Wang H; Guller M; Gourin CG; Rooper LM; Vosler PS; Tan M; D'Souza G; Koch WM; Eisele DW; Seiwert TY; Fakhry C; Pardoll DM; Mandal R
JAMA Otolaryngol Head Neck Surg; 2022 Jan; 148(1):70-79. PubMed ID: 34792560
[TBL] [Abstract][Full Text] [Related]
10. The frequency of high-risk human papillomavirus types, HPV16 lineages, and their relationship with p16
Pakdel F; Farhadi A; Pakdel T; Andishe-Tadbir A; Alavi P; Behzad-Behbahani A; Ashraf MJ
Braz J Microbiol; 2021 Mar; 52(1):195-206. PubMed ID: 33169334
[TBL] [Abstract][Full Text] [Related]
11. HPV Integration in HNSCC Correlates with Survival Outcomes, Immune Response Signatures, and Candidate Drivers.
Koneva LA; Zhang Y; Virani S; Hall PB; McHugh JB; Chepeha DB; Wolf GT; Carey TE; Rozek LS; Sartor MA
Mol Cancer Res; 2018 Jan; 16(1):90-102. PubMed ID: 28928286
[TBL] [Abstract][Full Text] [Related]
12. Signatures of somatic mutations and gene expression from p16INK4A positive head and neck squamous cell carcinomas (HNSCC).
Saba NF; Dinasarapu AR; Magliocca KR; Dwivedi B; Seby S; Qin ZS; Patel M; Griffith CC; Wang X; El-Deiry M; Steuer CE; Kowalski J; Shin DM; Zwick ME; Chen ZG
PLoS One; 2020; 15(9):e0238497. PubMed ID: 32986729
[TBL] [Abstract][Full Text] [Related]
13. Poor prognostic factors in human papillomavirus-positive head and neck cancer: who might not be candidates for de-escalation treatment?
Yoo SH; Ock CY; Keam B; Park SJ; Kim TM; Kim JH; Jeon YK; Chung EJ; Kwon SK; Hah JH; Kwon TK; Jung KC; Kim DW; Wu HG; Sung MW; Heo DS
Korean J Intern Med; 2019 Nov; 34(6):1313-1323. PubMed ID: 30428646
[TBL] [Abstract][Full Text] [Related]
14. Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
Salazar CR; Anayannis N; Smith RV; Wang Y; Haigentz M; Garg M; Schiff BA; Kawachi N; Elman J; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
Int J Cancer; 2014 Nov; 135(10):2404-12. PubMed ID: 24706381
[TBL] [Abstract][Full Text] [Related]
15. PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas.
Riva G; Pecorari G; Biolatti M; Pautasso S; Lo Cigno I; Garzaro M; Dell'Oste V; Landolfo S
Mol Biol Rep; 2019 Jun; 46(3):3333-3347. PubMed ID: 30980272
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.
López RV; Levi JE; Eluf-Neto J; Koifman RJ; Koifman S; Curado MP; Michaluart-Junior P; Figueiredo DL; Saggioro FP; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho F; Tajara EH; Waterboer T; Boffetta P; Brennan P; Wünsch-Filho V
Cancer Causes Control; 2014 Apr; 25(4):461-71. PubMed ID: 24474236
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Epigenomic Alterations in HPV16+ Head and Neck Squamous Cell Carcinomas.
Berglund A; Muenyi C; Siegel EM; Ajidahun A; Eschrich SA; Wong D; Hendrick LE; Putney RM; Kim S; Hayes DN; Shibata D
Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):858-869. PubMed ID: 35064062
[TBL] [Abstract][Full Text] [Related]
18. HPV-positive status associated with inflamed immune microenvironment and improved response to anti-PD-1 therapy in head and neck squamous cell carcinoma.
Wang J; Sun H; Zeng Q; Guo XJ; Wang H; Liu HH; Dong ZY
Sci Rep; 2019 Sep; 9(1):13404. PubMed ID: 31527697
[TBL] [Abstract][Full Text] [Related]
19. The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer.
Wichmann G; Rosolowski M; Krohn K; Kreuz M; Boehm A; Reiche A; Scharrer U; Halama D; Bertolini J; Bauer U; Holzinger D; Pawlita M; Hess J; Engel C; Hasenclever D; Scholz M; Ahnert P; Kirsten H; Hemprich A; Wittekind C; Herbarth O; Horn F; Dietz A; Loeffler M;
Int J Cancer; 2015 Dec; 137(12):2846-57. PubMed ID: 26095926
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation derived systemic inflammation indices are associated with head and neck cancer development and survival.
Ambatipudi S; Langdon R; Richmond RC; Suderman M; Koestler DC; Kelsey KT; Kazmi N; Penfold C; Ho KM; McArdle W; Ring SM; Pring M; Waterboer T; Pawlita M; Gaunt TR; Davey Smith G; Thomas S; Ness AR; Relton CL
Oral Oncol; 2018 Oct; 85():87-94. PubMed ID: 30220325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
